Humacyte (NASDAQ:HUMA) and Passage Bio (NASDAQ:PASG) Head to Head Review
Humacyte (NASDAQ:HUMA – Get Free Report) and Passage Bio (NASDAQ:PASG – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Analyst Ratings This is a summary of current […]
More Stories
InvenTrust Properties (NYSE:IVT) Upgraded at Jefferies Financial Group
Jefferies Financial Group upgraded shares of InvenTrust Properties (NYSE:IVT – Free Report) from a hold rating to a buy rating...
Jefferies Financial Group Issues Positive Forecast for Wyndham Hotels & Resorts (NYSE:WH) Stock Price
Wyndham Hotels & Resorts (NYSE:WH – Free Report) had its target price lifted by Jefferies Financial Group from $107.00 to...
Welltower (NYSE:WELL) Upgraded at Jefferies Financial Group
Jefferies Financial Group upgraded shares of Welltower (NYSE:WELL – Free Report) from a hold rating to a buy rating in...
Raymond James Downgrades Parsons (NYSE:PSN) to Market Perform
Raymond James cut shares of Parsons (NYSE:PSN – Free Report) from an outperform rating to a market perform rating in...
Healthcare Realty Trust (NYSE:HR) Cut to “Underperform” at Wedbush
Wedbush lowered shares of Healthcare Realty Trust (NYSE:HR – Free Report) from a neutral rating to an underperform rating in...
A SPAC III Acquisition Corp. Announces Separation of Class A Ordinary Shares and Rights
On January 1, 2025, A SPAC III Acquisition Corp. made public that holders of the company’s units now have the...